Back to search

Article

Increasing phagocytosis of microglia through targeting CD33 with liposomes displaying glycan ligands

2021-05-09

Abstract excerpt

CD33 is an immunomodulatory receptor expressed on microglia and genetically linked to Alzheimer’s disease (AD) susceptibility. While antibodies targeting CD33 have entered clinical trials to treat neurodegeneration, it is unknown whether the glycan-binding properties of CD33 can be exploited to modulate microglia. Here, we use liposomes that multivalently display glycan ligands of CD33 (CD33L liposomes) to engage...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e2c9ddb6-d63b-57fb-913e-1e7b37247b26
DOI
10.1101/2021.05.08.443135
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Increasing phagocytosis of microglia through targeting CD33 with liposomes displaying glycan ligandsDOI 10.1101/2021.05.08.443135
Select a neighboring publication to make it the new centre.